A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

BACKGROUND: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a major problem for public health, affecting both developed and developing countries. Impaired fasting plasma glucose has been previously associated with endothelial dysfunction, higher levels of inflam...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: López-Jaramillo, Patricio, Pradilla, Lina P, Lahera, Vicente, Sieger, Federico A Silva, Rueda-Clausen, Christian F, Márquez, Gustavo A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2006
Pynciau:
Study Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1594582/
https://ncbi.nlm.nih.gov/pubmed/16959033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-7-28
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg